Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
UPDATE (4/15/26): In a resolution from the Clinton County Council, the council demanded the resignation of both Richard Kelly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results